nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Drug ineffective—Mesalazine—Crohn's disease	0.118	0.2	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.0421	0.102	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.0395	0.0956	CbGpPWpGaD
Adapalene—Papilloedema—Prednisone—Crohn's disease	0.0339	0.0579	CcSEcCtD
Adapalene—Burning sensation—Mesalazine—Crohn's disease	0.0293	0.05	CcSEcCtD
Adapalene—Dermatitis atopic—Mesalazine—Crohn's disease	0.0275	0.047	CcSEcCtD
Adapalene—Feeling hot—Mesalazine—Crohn's disease	0.026	0.0443	CcSEcCtD
Adapalene—Rash pustular—Mesalazine—Crohn's disease	0.0256	0.0436	CcSEcCtD
Adapalene—Skin discolouration—Mesalazine—Crohn's disease	0.0226	0.0385	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.0206	0.0498	CbGpPWpGaD
Adapalene—Skin exfoliation—Mesalazine—Crohn's disease	0.0195	0.0332	CcSEcCtD
Adapalene—Optic neuritis—Prednisone—Crohn's disease	0.0175	0.0299	CcSEcCtD
Adapalene—Eczema—Mesalazine—Crohn's disease	0.0165	0.0281	CcSEcCtD
Adapalene—Eye pain—Mesalazine—Crohn's disease	0.0164	0.028	CcSEcCtD
Adapalene—Dermatitis bullous—Mesalazine—Crohn's disease	0.0155	0.0264	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisone—Crohn's disease	0.0146	0.0249	CcSEcCtD
Adapalene—Face oedema—Mesalazine—Crohn's disease	0.0143	0.0244	CcSEcCtD
Adapalene—Dry skin—Mesalazine—Crohn's disease	0.0136	0.0231	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.013	0.0314	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.0124	0.0301	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Mesalazine—Crohn's disease	0.0117	0.0199	CcSEcCtD
Adapalene—Conjunctivitis—Mesalazine—Crohn's disease	0.0111	0.0189	CcSEcCtD
Adapalene—Skin exfoliation—Prednisone—Crohn's disease	0.0103	0.0176	CcSEcCtD
Adapalene—Hepatitis—Mesalazine—Crohn's disease	0.0102	0.0175	CcSEcCtD
Adapalene—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00988	0.0168	CcSEcCtD
Adapalene—RXRA—Recycling of bile acids and salts—ALB—Crohn's disease	0.00966	0.0234	CbGpPWpGaD
Adapalene—Erythema—Mesalazine—Crohn's disease	0.00891	0.0152	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00864	0.0209	CbGpPWpGaD
Adapalene—Rash—Mercaptopurine—Crohn's disease	0.00845	0.0144	CcSEcCtD
Adapalene—Dermatitis—Mercaptopurine—Crohn's disease	0.00844	0.0144	CcSEcCtD
Adapalene—Angioedema—Mesalazine—Crohn's disease	0.00814	0.0139	CcSEcCtD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.0079	0.0191	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00775	0.0187	CbGpPWpGaD
Adapalene—Face oedema—Prednisone—Crohn's disease	0.00756	0.0129	CcSEcCtD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00743	0.018	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00743	0.018	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—FADS1—Crohn's disease	0.00718	0.0174	CbGpPWpGaD
Adapalene—Dry skin—Prednisone—Crohn's disease	0.00718	0.0122	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.00703	0.017	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00648	0.0157	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—SOCS1—Crohn's disease	0.00639	0.0154	CbGpPWpGaD
Adapalene—Pain—Mesalazine—Crohn's disease	0.00622	0.0106	CcSEcCtD
Adapalene—RARA—Adipogenesis—SOCS1—Crohn's disease	0.006	0.0145	CbGpPWpGaD
Adapalene—Hypersensitivity—Azathioprine—Crohn's disease	0.00588	0.01	CcSEcCtD
Adapalene—Urticaria—Mesalazine—Crohn's disease	0.00578	0.00986	CcSEcCtD
Adapalene—RXRG—Adipogenesis—SMAD3—Crohn's disease	0.00551	0.0133	CbGpPWpGaD
Adapalene—Hypersensitivity—Mesalazine—Crohn's disease	0.00536	0.00914	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00525	0.0127	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—SMAD3—Crohn's disease	0.00518	0.0125	CbGpPWpGaD
Adapalene—Pruritus—Mesalazine—Crohn's disease	0.00515	0.00878	CcSEcCtD
Adapalene—RXRA—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00505	0.0122	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00504	0.0122	CbGpPWpGaD
Adapalene—Rash—Azathioprine—Crohn's disease	0.00504	0.00859	CcSEcCtD
Adapalene—Dermatitis—Azathioprine—Crohn's disease	0.00503	0.00858	CcSEcCtD
Adapalene—RARG—Gene Expression—PTRF—Crohn's disease	0.00491	0.0119	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.00484	0.0117	CbGpPWpGaD
Adapalene—Erythema—Prednisone—Crohn's disease	0.00472	0.00804	CcSEcCtD
Adapalene—Rash—Mesalazine—Crohn's disease	0.00459	0.00782	CcSEcCtD
Adapalene—Dermatitis—Mesalazine—Crohn's disease	0.00458	0.00781	CcSEcCtD
Adapalene—RXRG—Gene Expression—PTRF—Crohn's disease	0.00449	0.0109	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	0.00442	0.0107	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PTRF—Crohn's disease	0.0044	0.0106	CbGpPWpGaD
Adapalene—Angioedema—Prednisone—Crohn's disease	0.00431	0.00735	CcSEcCtD
Adapalene—RXRB—Gene Expression—PTRF—Crohn's disease	0.00422	0.0102	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PTRF—Crohn's disease	0.00422	0.0102	CbGpPWpGaD
Adapalene—Convulsion—Prednisone—Crohn's disease	0.00409	0.00697	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00387	0.00936	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	0.00357	0.00863	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—SOCS1—Crohn's disease	0.00313	0.00757	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00308	0.00744	CbGpPWpGaD
Adapalene—Urticaria—Prednisone—Crohn's disease	0.00306	0.00521	CcSEcCtD
Adapalene—RARG—Gene Expression—ZFP36L1—Crohn's disease	0.00294	0.00711	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00291	0.00704	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisone—Crohn's disease	0.00284	0.00484	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00281	0.0068	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00276	0.00667	CbGpPWpGaD
Adapalene—Pruritus—Prednisone—Crohn's disease	0.00272	0.00464	CcSEcCtD
Adapalene—RXRA—Adipogenesis—SMAD3—Crohn's disease	0.0027	0.00653	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ZFP36L1—Crohn's disease	0.00269	0.0065	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00265	0.0064	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00265	0.0064	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ZFP36L1—Crohn's disease	0.00264	0.00638	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00262	0.00635	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ZFP36L1—Crohn's disease	0.00253	0.00612	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ZFP36L1—Crohn's disease	0.00253	0.00612	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—STAT3—Crohn's disease	0.00252	0.00609	CbGpPWpGaD
Adapalene—RARG—Gene Expression—DNMT3A—Crohn's disease	0.0025	0.00605	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00248	0.00599	CbGpPWpGaD
Adapalene—Rash—Prednisone—Crohn's disease	0.00243	0.00414	CcSEcCtD
Adapalene—Dermatitis—Prednisone—Crohn's disease	0.00242	0.00413	CcSEcCtD
Adapalene—RARA—Adipogenesis—STAT3—Crohn's disease	0.00237	0.00573	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00235	0.00569	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00235	0.00569	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.00233	0.00563	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—DNMT3A—Crohn's disease	0.00229	0.00553	CbGpPWpGaD
Adapalene—RARB—Gene Expression—DNMT3A—Crohn's disease	0.00224	0.00542	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.00223	0.0054	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.0022	0.00532	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PTRF—Crohn's disease	0.0022	0.00532	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TNF—Crohn's disease	0.00218	0.00527	CbGpPWpGaD
Adapalene—RARA—Gene Expression—DNMT3A—Crohn's disease	0.00215	0.0052	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—DNMT3A—Crohn's disease	0.00215	0.0052	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TNF—Crohn's disease	0.00205	0.00496	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00201	0.00487	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00197	0.00477	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00193	0.00466	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00189	0.00458	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00189	0.00458	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00181	0.00437	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IL6—Crohn's disease	0.00176	0.00425	CbGpPWpGaD
Adapalene—RARG—Gene Expression—HSPA1B—Crohn's disease	0.00169	0.00408	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00166	0.00401	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—IL6—Crohn's disease	0.00165	0.004	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	0.00162	0.00393	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.00157	0.0038	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—HSPA1B—Crohn's disease	0.00155	0.00374	CbGpPWpGaD
Adapalene—RARB—Gene Expression—HSPA1B—Crohn's disease	0.00152	0.00366	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.00151	0.00364	CbGpPWpGaD
Adapalene—RARG—Gene Expression—UBE2D1—Crohn's disease	0.00148	0.00358	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00147	0.00354	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—HSPA1B—Crohn's disease	0.00145	0.00351	CbGpPWpGaD
Adapalene—RARA—Gene Expression—HSPA1B—Crohn's disease	0.00145	0.00351	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00138	0.00333	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—UBE2D1—Crohn's disease	0.00135	0.00328	CbGpPWpGaD
Adapalene—RARB—Gene Expression—UBE2D1—Crohn's disease	0.00133	0.00321	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ZFP36L1—Crohn's disease	0.00132	0.00319	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PLA2G4F—Crohn's disease	0.0013	0.00314	CbGpPWpGaD
Adapalene—RARA—Gene Expression—UBE2D1—Crohn's disease	0.00127	0.00308	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—UBE2D1—Crohn's disease	0.00127	0.00308	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—STAT3—Crohn's disease	0.00123	0.00298	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.00116	0.00281	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—DNMT3A—Crohn's disease	0.00112	0.00271	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTMR3—Crohn's disease	0.0011	0.00267	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—Crohn's disease	0.00107	0.00258	CbGpPWpGaD
Adapalene—RARG—Gene Expression—SMAD3—Crohn's disease	0.00106	0.00256	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000986	0.00239	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SMAD3—Crohn's disease	0.000969	0.00234	CbGpPWpGaD
Adapalene—RARB—Gene Expression—SMAD3—Crohn's disease	0.000951	0.0023	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SMAD3—Crohn's disease	0.000929	0.00225	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SMAD3—Crohn's disease	0.000911	0.0022	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SMAD3—Crohn's disease	0.000911	0.0022	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—Crohn's disease	0.000862	0.00208	CbGpPWpGaD
Adapalene—RXRA—Metabolism—FADS1—Crohn's disease	0.000859	0.00208	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GPX4—Crohn's disease	0.000804	0.00194	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000785	0.0019	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GCKR—Crohn's disease	0.000777	0.00188	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HSPA1B—Crohn's disease	0.000757	0.00183	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—UBE2D1—Crohn's disease	0.000664	0.00161	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TYK2—Crohn's disease	0.000606	0.00146	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—JAK2—Crohn's disease	0.000578	0.0014	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000555	0.00134	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000528	0.00128	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000486	0.00117	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SMAD3—Crohn's disease	0.000475	0.00115	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—STAT3—Crohn's disease	0.000424	0.00103	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—Crohn's disease	0.000367	0.000888	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—Crohn's disease	0.000296	0.000716	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALB—Crohn's disease	0.000247	0.000598	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—Crohn's disease	0.000216	0.000523	CbGpPWpGaD
